← Every applicant
Shandong FDA Approvals
12 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| SUGAMMADEX SODIUMNew drugOct 6, 2026SOLUTION, INTRAVENOUS |
| KETOROLAC TROMETHAMINENew drugSep 23, 2026INJECTABLE, INJECTION |
| BRIVARACETAMNew drugJul 13, 2026SOLUTION, INTRAVENOUS |
| OXALIPLATINNew drugJan 15, 2026INJECTABLE, INTRAVENOUS |
| ISOFLURANENew drugNov 4, 2025LIQUID, INHALATION |
| OSELTAMIVIR PHOSPHATENew drugJul 9, 2025CAPSULE, ORAL |
| ROCURONIUM BROMIDENew drugJul 12, 2024INJECTABLE, INJECTION |
| TADALAFILNew drugMar 4, 2024TABLET, ORAL |
| SEVOFLURANENew drugAug 18, 2023LIQUID, INHALATION |
| PIPERACILLIN AND TAZOBACTAMNew drugApr 14, 2023INJECTABLE, INJECTION |
| MILRINONE LACTATENew drugJan 23, 2023INJECTABLE, INJECTION |
| ISOSORBIDE MONONITRATENew drugApr 29, 2022TABLET, EXTENDED RELEASE, ORAL |